Arogya World honored 41 organizations for outstanding employee wellbeing initiatives at the 2025 Global Summit, emphasizing ...

A recent study by The George Institute and Imperial College London highlights the exclusion of women from heat adaptation ...

AIIMS New Delhi successfully led India's first clinical trial of the Supernova stent retriever, demonstrating effective and ...

Explore the rising prevalence of weight-loss drugs in India, their impact on health and wellness, and the critical balance ...

The ICMR has funded the IPIROC study to evaluate a cost-effective dosing strategy for PARP inhibitor rucaparib in ovarian cancer patients, aiming to enhance access and reduce side effects.

Israeli and Dutch researchers develop FibrilPaint and FibrilRuler to measure Tau amyloid fibrils in real-time, potentially revolutionizing Alzheimer's diagnostics and drug development.

A comprehensive study conducted by AIIMS, New Delhi reveals no evidence connecting COVID-19 vaccination to sudden deaths in ...

AIIMS New Delhi successfully conducted India's first clinical trial for an indigenously developed advanced stroke device, the ...

The Asian Development Bank (ADB) has approved a $108 million results-based loan to support the Government of Mizoram in ...

India is positioning itself as a global leader in the intersection of artificial intelligence and traditional medicine ...

The Rajendra Institute of Medical Sciences (RIMS) building is in a state of severe disrepair, causing safety concerns for patients and staff. Immediate attention is required as structural issues ...

Afghan Health Minister Mawlawi Noor Jalal Jalali is set to visit India next week, marking the third ministerial-level trip from Kabul in recent months. This trip aims to enhance healthcare cooperation ...